Treatment goals for patients with T2DM and CKD

Treatment goals for patients with TDM and CKD
10' education - July 13, 2021 - Prof. Peter Rossing, MD - Online CME

Subtitles: English, French, German & more

  • Overview

    Prof. Rossing talks about setting treatment goals for patients with T2DM and CKD. These treatment goals are not limited to risk factor control but are also focused on organ protection.

  • Educational information

    This lecture by Prof. Peter Rossing was part of the EBAC-accredited symposium "SGLT2i in CKD: How to overcome clinical inertia?" held during the virtual ERA EDTA 2021 congress.

  • Faculty

    Prof. Peter Rossing is head of research and chief physician at the Steno Diabetes Center in Copenhagen, Denmark.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim and Lilly.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free